Product Information
TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP is a generic product labeled by Chartwell RX LLC, priced at $0.1221 per EA under NDC 62135052990. Its NADAC has been published 159 times since Aug 9, 2023.
FDA first approved this application on Dec 9, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 37.5 mg/1; mg/1
Manufacturer
Chartwell RX LLCNDC
62135052990
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; TRIAMTERENEApproval Type
Generic (ANDA)
FDA Application
ANDA201407FDA Approved
12/9/2011
TE Code
AB
On Market Since
12/9/2011
Pharmacological Classes
Price Statistics
The NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP has been published 159 times since Aug 9, 2023, and over the history we have for it it has declined 15.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1221 per EA |
|---|---|
| All-time high | $0.1436 (Aug 16, 2023) |
| All-time low | $0.0844 (Jul 17, 2024) |
| 52-week high | $0.1221 |
| 52-week low | $0.1128 |
| Median price | $0.1189 |
| Average price | $0.1155 |
| Largest weekly change | +46.0% (Aug 21, 2024) |
| Weeks tracked | 159 |
| Tracking since | Aug 9, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TRIAMTERENE AND HYDROCHLOROTHIAZIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP, manufactured by Chartwell RX LLC, is $0.1221 per EA (NDC 62135052990), effective Aug 19, 2026.
How has the price of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP changed over time?
Over the history we have for it, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP has declined 15.0%. It has been tracked across 159 weekly CMS publications since Aug 9, 2023.
What are the highest and lowest recorded NADAC prices for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP?
Since Aug 9, 2023, the NADAC for TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP has ranged from a low of $0.0844 (Jul 17, 2024) to a high of $0.1436 (Aug 16, 2023), with a median of $0.1189 per EA.
Are there cheaper alternatives to TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP?
No other NADAC-published product currently shares the active ingredient and strength of TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP?
TRIAMTERENE-HYDROCHLOROTHIAZIDE 37.5-25 MG CP (NDC 62135052990) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.